TY - JOUR
T1 - Laboratory evaluation of hypercoagulable states
AU - Van Cott, E. M.
AU - Laposata, M.
PY - 1998
Y1 - 1998
N2 - The number of well-characterized hereditary and acquired hypercoagulable conditions is increasing, such that in many thrombophilic patients, the laboratory can now identify a hypercoagulable condition. This review describes the currently known hypercoagulable states that predispose patients to venous, and in some instances, arterial thrombosis. For each condition, the discussion includes the incidence, magnitude of the thrombotic risk in the general population in comparison with symptomatic families, synergistic interactions among the various hypercoagulable conditions, molecular pathogenesis, and interpretation of laboratory test results. In addition, recommendations for laboratory testing are summarized.
AB - The number of well-characterized hereditary and acquired hypercoagulable conditions is increasing, such that in many thrombophilic patients, the laboratory can now identify a hypercoagulable condition. This review describes the currently known hypercoagulable states that predispose patients to venous, and in some instances, arterial thrombosis. For each condition, the discussion includes the incidence, magnitude of the thrombotic risk in the general population in comparison with symptomatic families, synergistic interactions among the various hypercoagulable conditions, molecular pathogenesis, and interpretation of laboratory test results. In addition, recommendations for laboratory testing are summarized.
UR - http://www.scopus.com/inward/record.url?scp=0032412683&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032412683&partnerID=8YFLogxK
U2 - 10.1016/S0889-8588(05)70047-2
DO - 10.1016/S0889-8588(05)70047-2
M3 - Article
C2 - 9922930
AN - SCOPUS:0032412683
SN - 0889-8588
VL - 12
SP - 1141
EP - 1166
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
IS - 6
ER -